Physician

Allison Beth Herbst, MD

According to 2025 Medicare claims, Allison Herbst, MD (NPI: 1689675068) practices endocrinology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08057-3132.

Herbst's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 1,947 HCPCS/CPT codes, and received $101,658 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 5,136 prescription claims across 601 beneficiaries totaling $1,440,350 in drug costs, led by Ozempic (Semaglutide). DME data shows 347 claims. Open Payments data shows 18 records totaling $447. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $717,468 to $1,440,350. For DME billing, reported payments rose steadily, from $9,071 to $91,494.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	529	1,015	$86,066
2016	490	999	$83,531
2017	440	913	$73,339
2018	436	1,019	$75,696
2019	398	1,163	$77,734
2020	384	1,007	$65,452
2021	383	1,028	$82,739
2022	398	1,503	$88,648
2023	402	1,627	$93,803
2024	403	1,947	$101,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	444	2,953	$717,468
2016	421	3,061	$717,885
2017	456	3,584	$1,004,886
2018	489	3,948	$1,159,883
2019	488	4,074	$1,242,994
2020	520	4,687	$1,491,248
2021	561	4,888	$1,762,367
2022	575	4,968	$1,795,304
2023	565	4,715	$1,757,295
2024	601	5,136	$1,440,350

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	279	566	$23,512
2016	193	372	$11,199
2017	165	330	$6,281
2018	206	448	$26,643
2019	188	455	$35,883
2020	178	539	$54,067
2021	169	539	$60,385
2022	137	434	$40,216
2023	125	426	$47,145
2024	133	347	$94,092

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	20	23	$127
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	28	28	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	347	657	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	22	26	$70
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	65	129	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	133	7,091	$221,930
Januvia	Sitagliptin Phosphate	150	9,720	$172,717
Trulicity	Dulaglutide	88	4,611	$149,399
Jardiance	Empagliflozin	116	7,663	$145,343
Mounjaro	Tirzepatide	81	3,416	$119,645

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	48	157	$85,809
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	18	18	$3,779
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	24	$2,665
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	46	103	$1,771
A4259	Lancets, per box of 100	N	21	45	$67

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$447	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allison Beth Herbst, MD?

Tedicare shows public-source Medicare data for Allison Beth Herbst, MD (NPI 1689675068), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allison Beth Herbst, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allison Beth Herbst, MD?

Allison Beth Herbst, MD is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Allison Beth Herbst, MD have Open Payments data?

Allison Beth Herbst, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.